COLUMBUS, Ohio – Ohio Life Sciences (OLS) is thrilled to announce the addition of Todd Ponsky and Sam Privitera to its Board of Administrators following a unanimous vote at this week’s board assembly.
Eddie Pauline, President and CEO of Ohio Life Sciences, extends a heartfelt congratulations to each Mr. Ponsky and Mr. Privitera. “We’re extremely lucky to have such distinguished people be part of our board. Their experience and imaginative and prescient might be invaluable in guiding our group in the direction of new heights in 2024 and past,” stated Pauline.
Dr. Todd Ponsky holds a number of roles – lnterim Vice President, Innovation Ventures, Professor of Surgical procedure, College of Cincinnati, and pediatric surgeon at Cincinnati Youngsters’s Hospital Medical Middle and Akron Youngsters’s Hospital – and a various background in medical science. Because the Director of Medical Development and Transformation at Cincinnati Youngsters’s Hospital, he has pioneered developments in pediatric surgical procedure, notably being the primary to carry out single-port surgical procedure in kids. Dr. Ponsky has had an in depth tutorial journey as each a pupil and professor, and he’s contributed considerably to medical literature with over 125 manuscripts, three textbooks, and a number of chapters. His management roles in a number of prestigious medical societies, coupled together with his modern contributions to pediatric surgical procedure and medical training, notably founding GlobalcastMD, spotlight his distinctive match for the board. “Because the primary kids’s hospital within the nation, Cincinnati Youngsters’s Hospital acknowledges the significance of a robust life sciences business. I’m thrilled to help Ohio Life Sciences mission of serving to to drive lifesaving innovation and financial progress,” stated Ponsky.
Sam Privitera brings a wealth of expertise because the Chief Technical Officer at AtriCure, the place he oversees Analysis, Product Growth, Operations, and High quality Assurance. AtriCure, identified for its modern applied sciences in treating Afib and associated situations, advantages from Mr. Privitera’s management in managing built-in manufacturing programs and coordinating high quality programs. His contributions have been pivotal in creating AtriCure’s groundbreaking medical units, and his in depth expertise in delivering best-in-class merchandise throughout varied medical areas is complemented by his function on the boards of the Cincinnati Chapter of the American Coronary heart Affiliation and the Advisory Board for the College of Biomedical Engineering at SUNY Buffalo. His engagement in these various boards, alongside together with his wealthy portfolio of over 50 US patents and the event of quite a few associates, makes him a superb match for the Ohio Life Sciences board. “Ohio Life Sciences is a crucial useful resource and advocate for our life sciences business that Atricure has benefited from. I’m proud to have a possibility to assist information the strategic course of the group,” stated Privitera.
Ohio Life Sciences is dedicated to fostering progress and innovation within the life sciences. The addition of Dr. Ponsky and Mr. Privitera to the board, and the board’s unanimous approval, displays these people’ capability to contribute considerably to the group’s targets and rising management throughout the state.
